The use of MOTs-C as a companion to GLP-1s, to prevent muscle loss, might get around this shortcoming of GLP-1s, but rigorous research is needed to prove [its effectiveness]
That said, "no serious toxicity in animal models" is not the same as "proven safe in humans long-term," and anyone with a personal or family history of cancer should treat the angiogenic mechanism above as a genuine reason to talk to a qualified clinician before starting
[ Google scholar ] Kang YA, Choi HR, Na JI, Huh CH, Kim MJ, Youn SW, et al
If this concerns you, purchase 0.3 ml syringes with half-unit markings, which are available at most pharmacies without a prescription
Three different mechanisms of GST-catalyzed isomerization are known: (i) carbon-carbon double bond shifts, (ii) intramolecular redox reactions and (iii) cis-trans isomerizations 21
The starting dose is typically 25 units (1.5mg) twice weekly